Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
Active, not recruiting · NCT03036930 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 2 | 2026-09-14 | NCT03036930 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | United States | 392 |
| Mayo Clinic in Rochester | Rochester | United States | 687 |
| Northwestern University | Chicago | United States | 727 |
| UCSF Medical Center-Mount Zion | San Francisco | United States | 26 |
| UNC Lineberger Comprehensive Cancer Center | Chapel Hill | United States | 243 |
| University of Alabama at Birmingham Cancer Center | Birmingham | United States | 186 |